12/5
08:00 am
cnmd
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
Medium
Report
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
11/6
05:26 pm
cnmd
CONMED (NYSE:CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $58.00 to $52.00. They now have a "neutral" rating on the stock.
Low
Report
CONMED (NYSE:CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $58.00 to $52.00. They now have a "neutral" rating on the stock.
11/6
11:11 am
cnmd
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Medium
Report
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
11/6
10:50 am
cnmd
CONMED (NYSE:CNMD) had its price target lowered by analysts at Wells Fargo & Company from $57.00 to $47.00. They now have an "equal weight" rating on the stock.
Medium
Report
CONMED (NYSE:CNMD) had its price target lowered by analysts at Wells Fargo & Company from $57.00 to $47.00. They now have an "equal weight" rating on the stock.
11/6
12:10 am
cnmd
Conmed Corp (CNMD) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Challenges [Yahoo! Finance]
Low
Report
Conmed Corp (CNMD) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Challenges [Yahoo! Finance]
11/5
04:05 pm
cnmd
CONMED Corporation Announces Third Quarter 2025 Financial Results
Medium
Report
CONMED Corporation Announces Third Quarter 2025 Financial Results
10/8
01:00 pm
cnmd
CONMED Corporation (CNMD): A Bull Case Theory [Yahoo! Finance]
Low
Report
CONMED Corporation (CNMD): A Bull Case Theory [Yahoo! Finance]
10/2
04:05 pm
cnmd
CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025
Medium
Report
CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025
9/24
08:04 pm
cnmd
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
Medium
Report
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
9/9
04:05 pm
cnmd
CONMED Corporation Adds Kim Kelderman to its Board of Directors
Low
Report
CONMED Corporation Adds Kim Kelderman to its Board of Directors